Filing Details
- Accession Number:
- 0001140361-10-010860
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-03-09 12:00:00
- Reporting Period:
- 2010-03-05
- Filing Date:
- 2010-03-09
- Accepted Time:
- 2010-03-09 16:16:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874716 | Idexx Laboratories Inc | IDXX | In Vitro & In Vivo Diagnostic Substances (2835) | 010393723 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1184149 | W Jonathan Ayers | One Idexx Drive Westbrook ME 04092 | Chairman, President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-03-05 | 60,000 | $12.60 | 193,311 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-03-05 | 48,765 | $55.78 | 144,546 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2010-03-08 | 3,488 | $28.66 | 148,034 | No | 4 | M | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2010-03-05 | 60,000 | $0.00 | 60,000 | $12.60 |
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2010-03-08 | 3,488 | $0.00 | 3,488 | $28.66 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 760,320 | 2012-01-28 | No | 4 | M | Direct | |
| 0 | 2015-02-02 | No | 4 | M | Direct |
Footnotes
- Grant of option to buy shares of common stock exercisable in five equal annual increments of 172,064 shares beginning on 1/28/2003.
- Grant of option to buy shares of IDEXX Laboratories, Inc. common stock exercisable on 2/3/2010.
Billionaire Hedge Funds
